BCIM
British Columbia Investment Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,885
| Closed | -$1.82M | – | 712 |
|
|
2024
Q4 | $1.82M | Buy |
9,885
+1,291
| +15% | +$238K | 0.01% | 643 |
|
|
2024
Q3 | $1.69M | Sell |
8,594
-1,240
| -13% | -$244K | 0.01% | 640 |
|
|
2024
Q2 | $2.03M | Sell |
9,834
-41,290
| -81% | -$8.53M | 0.01% | 606 |
|
|
2024
Q1 | $13.9M | Buy |
51,124
+224
| +0.4% | +$60.7K | 0.1% | 155 |
|
|
2023
Q4 | $12M | Buy |
50,900
+1,267
| +3% | +$300K | 0.1% | 160 |
|
|
2023
Q3 | $9.73M | Buy |
49,633
+4,000
| +9% | +$784K | 0.09% | 153 |
|
|
2023
Q2 | $9.59M | Buy |
45,633
+93
| +0.2% | +$19.6K | 0.09% | 168 |
|
|
2023
Q1 | $9.19M | Buy |
45,540
+66
| +0.1% | +$13.3K | 0.1% | 185 |
|
|
2022
Q4 | $9.91M | Buy |
45,474
+10,450
| +30% | +$2.28M | 0.11% | 168 |
|
|
2022
Q3 | $6.89M | Buy |
35,024
+7,789
| +29% | +$1.53M | 0.08% | 215 |
|
|
2022
Q2 | $5.83M | Sell |
27,235
-4,956
| -15% | -$1.06M | 0.06% | 268 |
|
|
2022
Q1 | $9.14M | Sell |
32,191
-9,066
| -22% | -$2.57M | 0.06% | 264 |
|
|
2021
Q4 | $15.5M | Sell |
41,257
-3,429
| -8% | -$1.29M | 0.09% | 199 |
|
|
2021
Q3 | $18.4M | Sell |
44,686
-18,559
| -29% | -$7.66M | 0.11% | 160 |
|
|
2021
Q2 | $23.4M | Buy |
63,245
+9,345
| +17% | +$3.46M | 0.14% | 129 |
|
|
2021
Q1 | $15.6M | Sell |
53,900
-6,200
| -10% | -$1.8M | 0.11% | 173 |
|
|
2020
Q4 | $15M | Sell |
60,100
-7,500
| -11% | -$1.87M | 0.11% | 159 |
|
|
2020
Q3 | $15.3M | Sell |
67,600
-5,400
| -7% | -$1.22M | 0.13% | 138 |
|
|
2020
Q2 | $12.7M | Buy |
73,000
+27,300
| +60% | +$4.76M | 0.13% | 144 |
|
|
2020
Q1 | $5.77M | Buy |
45,700
+24,400
| +115% | +$3.08M | 0.1% | 185 |
|
|
2019
Q4 | $3.25M | Buy |
+21,300
| New | +$3.25M | 0.02% | 502 |
|